D1 Capital Partners L.P. Edwards Lifesciences Corp Transaction History

D1 Capital Partners L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $12.4 Million - $15.3 Million	-116,794 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $115 Million - $137 Million	-1,113,206 Reduced 90.5%	116,794 $13.2 Million
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $1.68 Million - $2.1 Million	20,000 Added 1.65%	1,230,000 $127 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $95.2 Million - $110 Million	1,210,000 New	1,210,000 $101 Million

1,417

470M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of D1 Capital Partners L.P., based on Form 13F filings with the SEC.

Stay updated on D1 Capital Partners L.P. with notifications on news.